Departments of Experimental Psychology and Psychiatry, University of Oxford, Oxford, UK.
School of Psychology and Clinical Language Sciences, University of Reading, Reading, UK.
Trials. 2022 Nov 16;23(1):942. doi: 10.1186/s13063-022-06833-5.
In the context of COVID-19, NHS Child and Adolescent Mental Health Services (CAMHS) and other children's mental health services have faced major challenges in providing psychological treatments that (i) work when delivered remotely and (ii) can be delivered efficiently to manage increases in referrals as social distancing measures have been relaxed. Anxiety problems are a common reason for referral to CAMHS, children with pre-existing anxiety problems are particularly vulnerable in the context of COVID-19, and there were concerns about increases in childhood anxiety as schools reopened. The proposed research will evaluate the clinical and cost-effectiveness of a brief online parent-led cognitive behavioural treatment (CBT) delivered by the OSI (Online Support and Intervention for child anxiety) platform with remote support from a CAMHS therapist compared to 'COVID-19 treatment as usual' (C-TAU) in CAMHS and other children's mental health services throughout the COVID-19 pandemic.
We will conduct a two-arm, multi-site, randomised controlled non-inferiority trial to evaluate the clinical and cost-effectiveness of OSI with therapist support compared to CAMHS and other child mental health services 'COVID-19 treatment as usual' (C-TAU) during the COVID-19 outbreak and to explore parent and therapists' experiences.
If non-inferiority is shown, the research will provide (1) a solution for efficient psychological treatment for child anxiety disorders while social distancing (for the COVID-19 context and future pandemics); (2) an efficient means of treatment delivery as 'normal service' resumes to enable CAMHS to cope with the anticipated increase in referrals; and (3) a demonstration of rapid, high-quality evaluation and application of online interventions within NHS CAMHS to drive forward much-needed further digital innovation and evaluation in CAMHS settings. The primary beneficiaries will be children with anxiety disorders and their families, NHS CAMHS teams, and commissioners who will access a potentially effective, cost-effective, and efficient treatment for child anxiety problems.
ISRCTN ISRCTN12890382 . Registered prospectively on 23 October 2020.
在 COVID-19 背景下，NHS 儿童和青少年心理健康服务 (CAMHS) 及其他儿童心理健康服务在提供以下心理治疗方面面临重大挑战：(i) 远程提供有效的治疗，以及 (ii) 能够高效地提供治疗，以管理随着社交距离措施放宽而增加的转介。焦虑问题是转介至 CAMHS 的常见原因，在 COVID-19 背景下，有先前焦虑问题的儿童特别脆弱，而且随着学校重新开放，人们担心儿童焦虑会增加。拟议的研究将评估 OSI（儿童焦虑在线支持和干预）平台上由家长主导的简短在线认知行为治疗 (CBT) 的临床和成本效益，该治疗由 CAMHS 治疗师提供远程支持，并与 CAMHS 和其他儿童心理健康服务在 COVID-19 大流行期间的“COVID-19 常规治疗”（C-TAU）进行比较。
我们将开展一项两臂、多地点、随机对照非劣效性试验，以评估 OSI 与治疗师支持相比 CAMHS 和其他儿童心理健康服务“COVID-19 常规治疗”（C-TAU）在 COVID-19 爆发期间的临床和成本效益，并探索家长和治疗师的经验。
如果显示非劣效性，该研究将提供 (1) 在社交距离期间（针对 COVID-19 背景和未来的大流行）为儿童焦虑症提供高效心理治疗的解决方案；(2) “正常服务”恢复后提供高效的治疗提供方式，使 CAMHS 能够应对预期增加的转介；(3) 在 NHS CAMHS 中快速、高质量地评估和应用在线干预措施的示范，以推动 CAMHS 环境中急需的进一步数字化创新和评估。主要受益者将是焦虑症儿童及其家庭、NHS CAMHS 团队和负责者，他们将获得针对儿童焦虑问题的潜在有效、具有成本效益且高效的治疗方法。
ISRCTN ISRCTN82306221。于 2020 年 10 月 23 日前瞻性注册。
